No Data
Bears Are Losing Control Over OrthoPediatrics (KIDS), Here's Why It's a 'Buy' Now
Shareholders in OrthoPediatrics (NASDAQ:KIDS) Have Lost 58%, as Stock Drops 7.6% This Past Week
Does OrthoPediatrics (KIDS) Have the Potential to Rally 36.3% as Wall Street Analysts Expect?
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $34
Truist Financial analyst Richard Newitter maintains $OrthoPediatrics(KIDS.US)$ with a hold rating, and sets the target price at $34.According to TipRanks data, the analyst has a success rate of 58.8%
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
Stifel analyst Rick Wise maintains $OrthoPediatrics(KIDS.US)$ with a buy rating, and maintains the target price at $40.According to TipRanks data, the analyst has a success rate of 58.5% and a total
A Quick Look at Today's Ratings for OrthoPediatrics(KIDS.US), With a Forecast Between $34 to $50
On Sep 13, major Wall Street analysts update their ratings for $OrthoPediatrics(KIDS.US)$, with price targets ranging from $34 to $50.Needham analyst Michael Matson maintains with a buy rating, and